Strategic Partnership Leverage the recent LGC clinical diagnostics partnership to position AccuGenomics as a preferred provider of NGS quality control materials for diagnostics labs, highlighting co-developed products and faster time-to-market benefits.

MRD Market Expansion Target oncology and hematology labs focusing on minimal residual disease and ctDNA monitoring, offering SNAQ-SEQ enhanced QC to reduce false negatives and improve assay sensitivity at the limit of detection.

Custom QC Solutions Promote ability to create custom internal standard mixtures for diverse NGS panels and workflows, appealing to CROs, diagnostic labs, and pharma partners conducting precision medicine studies.

Pathogen & QC Synergy Highlight existing pathogen testing standards and QC materials to expand into infectious disease labs seeking robust, scalable QC solutions across multiple assay platforms.

Small Team Agility Position as a nimble, customer-centric partner with rapid iteration capabilities and dedicated support for labs adopting new NGS QC materials, ideal for early adopters and pilot programs.